biguanides has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, T; Liu, Y; Wang, M; Xu, Y; Yang, M; Yuan, H; Zhang, Y | 1 |
| Chan, WL; Chen, JW; Chen, TJ; Chen, YC; Chiu, CC; Huang, CC; Leu, HB; Liang, Y; Lin, SJ | 1 |
2 other study(ies) available for biguanides and Cancer of Liver
| Article | Year |
|---|---|
Biguanides decorated albumin nanoparticles loading nintedanib for synergic enhanced hepatocellular carcinoma therapy.
Topics: Biguanides; Carcinoma, Hepatocellular; Humans; Indoles; Liver Neoplasms; Nanoparticles; Serum Albumin, Bovine; Tumor Microenvironment | 2021 |
Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
Topics: alpha-Glucosidases; Biguanides; Cohort Studies; Diabetes Mellitus; Digestive System Neoplasms; Humans; Hypoglycemic Agents; Insulin; Liver Neoplasms; Pancreatic Neoplasms; Proportional Hazards Models; Sampling Studies; Sulfonylurea Compounds; Taiwan; Thiazolidinediones | 2013 |